

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.64503645 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.64503645 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.37219626 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.37219626 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.30251885 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.88641762 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.74468564 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.26730782 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.26073668 |
| 10 | positive thymic T cell selection (GO:0045059) | 4.01686701 |
| 11 | cellular response to interleukin-15 (GO:0071350) | 3.93727366 |
| 12 | leukocyte aggregation (GO:0070486) | 3.93343778 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.88977446 |
| 14 | response to interleukin-15 (GO:0070672) | 3.82933195 |
| 15 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.79079234 |
| 16 | detection of bacterium (GO:0016045) | 3.79011760 |
| 17 | immunoglobulin mediated immune response (GO:0016064) | 3.77328286 |
| 18 | regulation of regulatory T cell differentiation (GO:0045589) | 3.70186607 |
| 19 | positive regulation of B cell differentiation (GO:0045579) | 3.68166871 |
| 20 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.62877412 |
| 21 | positive T cell selection (GO:0043368) | 3.62617130 |
| 22 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.53465588 |
| 23 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.50621476 |
| 24 | regulation of B cell differentiation (GO:0045577) | 3.45828746 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 3.43229733 |
| 26 | modulation by symbiont of host defense response (GO:0052031) | 3.43229733 |
| 27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.43229733 |
| 28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.43229733 |
| 29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.43229733 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 3.43229733 |
| 31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.42897217 |
| 32 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.39323289 |
| 33 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.39097399 |
| 34 | negative regulation of interleukin-12 production (GO:0032695) | 3.39070389 |
| 35 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.38231396 |
| 36 | mast cell activation (GO:0045576) | 3.37060541 |
| 37 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.36337095 |
| 38 | T cell selection (GO:0045058) | 3.35891949 |
| 39 | myeloid dendritic cell activation (GO:0001773) | 3.33921006 |
| 40 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.31628475 |
| 41 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.30507230 |
| 42 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.30507230 |
| 43 | regulation of tolerance induction (GO:0002643) | 3.30428646 |
| 44 | response to interferon-beta (GO:0035456) | 3.29410944 |
| 45 | negative regulation of phagocytosis (GO:0050765) | 3.27525799 |
| 46 | regulation of gamma-delta T cell activation (GO:0046643) | 3.27227881 |
| 47 | negative regulation of T cell mediated immunity (GO:0002710) | 3.27175061 |
| 48 | respiratory burst (GO:0045730) | 3.27015193 |
| 49 | thymic T cell selection (GO:0045061) | 3.25959451 |
| 50 | defense response to protozoan (GO:0042832) | 3.17773816 |
| 51 | positive regulation of tolerance induction (GO:0002645) | 3.17528973 |
| 52 | response to protozoan (GO:0001562) | 3.17072587 |
| 53 | response to peptidoglycan (GO:0032494) | 3.14938234 |
| 54 | regulation of mast cell degranulation (GO:0043304) | 3.14696588 |
| 55 | T cell migration (GO:0072678) | 3.14694993 |
| 56 | cytidine deamination (GO:0009972) | 3.14015964 |
| 57 | cytidine metabolic process (GO:0046087) | 3.14015964 |
| 58 | cytidine catabolic process (GO:0006216) | 3.14015964 |
| 59 | positive regulation of interferon-alpha production (GO:0032727) | 3.13921039 |
| 60 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.12573525 |
| 61 | neutrophil activation (GO:0042119) | 3.09240181 |
| 62 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.09058212 |
| 63 | cellular extravasation (GO:0045123) | 3.08658107 |
| 64 | response to type I interferon (GO:0034340) | 3.06400145 |
| 65 | detection of external biotic stimulus (GO:0098581) | 3.05959861 |
| 66 | cellular response to type I interferon (GO:0071357) | 3.05392635 |
| 67 | type I interferon signaling pathway (GO:0060337) | 3.05392635 |
| 68 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.05074257 |
| 69 | B cell mediated immunity (GO:0019724) | 3.04297335 |
| 70 | cellular response to zinc ion (GO:0071294) | 3.03360531 |
| 71 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.01184914 |
| 72 | regulation of RIG-I signaling pathway (GO:0039535) | 3.00368312 |
| 73 | T cell receptor signaling pathway (GO:0050852) | 3.00054057 |
| 74 | positive regulation of mast cell activation (GO:0033005) | 2.99870615 |
| 75 | regulation of interferon-alpha production (GO:0032647) | 2.99414336 |
| 76 | hepatocyte apoptotic process (GO:0097284) | 2.98996416 |
| 77 | definitive hemopoiesis (GO:0060216) | 2.98118896 |
| 78 | B cell receptor signaling pathway (GO:0050853) | 2.97290265 |
| 79 | positive regulation of antigen processing and presentation (GO:0002579) | 2.96393287 |
| 80 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.95616234 |
| 81 | T-helper 1 type immune response (GO:0042088) | 2.94085303 |
| 82 | positive regulation of granulocyte differentiation (GO:0030854) | 2.93859154 |
| 83 | granulocyte activation (GO:0036230) | 2.91123450 |
| 84 | microglial cell activation (GO:0001774) | 2.90537253 |
| 85 | myeloid cell activation involved in immune response (GO:0002275) | 2.89960676 |
| 86 | megakaryocyte development (GO:0035855) | 2.88913541 |
| 87 | myeloid dendritic cell differentiation (GO:0043011) | 2.88155447 |
| 88 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.87279401 |
| 89 | regulation of necroptotic process (GO:0060544) | 2.86674594 |
| 90 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.86445733 |
| 91 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.85903662 |
| 92 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.84797718 |
| 93 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.84446038 |
| 94 | negative regulation of innate immune response (GO:0045824) | 2.84080156 |
| 95 | NIK/NF-kappaB signaling (GO:0038061) | 2.83823324 |
| 96 | regulation of cell killing (GO:0031341) | 2.83590704 |
| 97 | actin nucleation (GO:0045010) | 2.82593488 |
| 98 | positive regulation of macrophage differentiation (GO:0045651) | 2.81340682 |
| 99 | response to muramyl dipeptide (GO:0032495) | 2.80895510 |
| 100 | cellular response to exogenous dsRNA (GO:0071360) | 2.80466029 |
| 101 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.79343352 |
| 102 | negative thymic T cell selection (GO:0045060) | 2.79252513 |
| 103 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.79143306 |
| 104 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.78956206 |
| 105 | cellular response to interferon-beta (GO:0035458) | 2.78917493 |
| 106 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.78138044 |
| 107 | activated T cell proliferation (GO:0050798) | 2.77746881 |
| 108 | interferon-gamma production (GO:0032609) | 2.77181674 |
| 109 | positive regulation of cell killing (GO:0031343) | 2.76465512 |
| 110 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.76015150 |
| 111 | ribosomal small subunit assembly (GO:0000028) | 2.72439453 |
| 112 | positive regulation of lamellipodium assembly (GO:0010592) | 2.72279019 |
| 113 | detection of other organism (GO:0098543) | 2.71451468 |
| 114 | pinocytosis (GO:0006907) | 2.70856512 |
| 115 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.70393170 |
| 116 | negative T cell selection (GO:0043383) | 2.69073411 |
| 117 | dendritic cell chemotaxis (GO:0002407) | 2.68911985 |
| 118 | necroptotic process (GO:0070266) | 2.66974618 |
| 119 | leukocyte cell-cell adhesion (GO:0007159) | 2.64791662 |
| 120 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.63090169 |
| 121 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.60946875 |
| 122 | myeloid leukocyte activation (GO:0002274) | 2.59568856 |
| 123 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.59455400 |
| 124 | leukocyte degranulation (GO:0043299) | 2.58888246 |
| 125 | dendritic cell migration (GO:0036336) | 2.57612065 |
| 126 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.52848332 |
| 127 | regulation of response to interferon-gamma (GO:0060330) | 2.52810407 |
| 128 | macrophage activation involved in immune response (GO:0002281) | 2.52601386 |
| 129 | dendritic cell differentiation (GO:0097028) | 2.51032338 |
| 130 | regulation of mast cell activation (GO:0033003) | 2.50298864 |
| 131 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.48978292 |
| 132 | regulation of T cell tolerance induction (GO:0002664) | 2.48734673 |
| 133 | response to interferon-alpha (GO:0035455) | 2.46389914 |
| 134 | natural killer cell activation (GO:0030101) | 2.45845081 |
| 135 | positive regulation of interferon-beta production (GO:0032728) | 2.45831423 |
| 136 | signal peptide processing (GO:0006465) | 2.43958099 |
| 137 | regulation of antigen processing and presentation (GO:0002577) | 2.43780648 |
| 138 | tolerance induction (GO:0002507) | 2.43230815 |
| 139 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.43002420 |
| 140 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.42834383 |
| 141 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.41501259 |
| 142 | response to host immune response (GO:0052572) | 2.41482578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.93108821 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.05238355 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.98225560 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.74794420 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.72263556 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.53848374 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.52044412 |
| 8 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.97847174 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.91676284 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.81323814 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.80478887 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.74211176 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.72383611 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.65244264 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.58622606 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.53973807 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.49934674 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.44856814 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.36918104 |
| 20 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.35536510 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.24445891 |
| 22 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21351914 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.19702275 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.12066630 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.10554856 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.08753118 |
| 27 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90963172 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 1.90800253 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89527819 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.88020429 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.87643091 |
| 32 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.86637498 |
| 33 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.82385481 |
| 34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.82021973 |
| 35 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.77702057 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77178997 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.75956463 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.75190133 |
| 39 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74219924 |
| 40 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74206069 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.74093727 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.71472206 |
| 43 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.70044508 |
| 44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.68641638 |
| 45 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59985408 |
| 46 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.55599014 |
| 47 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.53937449 |
| 48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.53903045 |
| 49 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.53123574 |
| 50 | UTX_26944678_Chip-Seq_JUKART_Human | 1.52309964 |
| 51 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.51769298 |
| 52 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47121124 |
| 53 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.43269784 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.40290644 |
| 55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39305701 |
| 56 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.38867563 |
| 57 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.37569087 |
| 58 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.37235849 |
| 59 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.36093555 |
| 60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30980460 |
| 61 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30238374 |
| 62 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25685862 |
| 63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25339409 |
| 64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23202919 |
| 65 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22868370 |
| 66 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.21917686 |
| 67 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21312113 |
| 68 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.20868692 |
| 69 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.19460697 |
| 70 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.18212371 |
| 71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17694964 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17434199 |
| 73 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14051002 |
| 74 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13931295 |
| 75 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.13383077 |
| 76 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.12841794 |
| 77 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12281279 |
| 78 | MAF_26560356_Chip-Seq_TH2_Human | 1.08627732 |
| 79 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07789134 |
| 80 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06774619 |
| 81 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06708296 |
| 82 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.05839685 |
| 83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05392716 |
| 84 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.05236001 |
| 85 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.04566118 |
| 86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01590300 |
| 87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01500131 |
| 88 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.99148394 |
| 89 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98491336 |
| 90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98060152 |
| 91 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96819797 |
| 92 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.96731453 |
| 93 | P300_27268052_Chip-Seq_Bcells_Human | 0.93583656 |
| 94 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93171324 |
| 95 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.93018594 |
| 96 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.92478563 |
| 97 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90248070 |
| 98 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.90159111 |
| 99 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.89227787 |
| 100 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.88549645 |
| 101 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87422980 |
| 102 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.87203226 |
| 103 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86703743 |
| 104 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.85820454 |
| 105 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85262499 |
| 106 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85187241 |
| 107 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.85011248 |
| 108 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.84520614 |
| 109 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.83676833 |
| 110 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.82099681 |
| 111 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.81888967 |
| 112 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81596180 |
| 113 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.80743864 |
| 114 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.80565652 |
| 115 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79874922 |
| 116 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79463803 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79446276 |
| 118 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79263522 |
| 119 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.79171720 |
| 120 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.77812375 |
| 121 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77700677 |
| 122 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.75907478 |
| 123 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.75838777 |
| 124 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.74380850 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.19502809 |
| 2 | MP0009785_altered_susceptibility_to | 3.33561711 |
| 3 | MP0005671_abnormal_response_to | 3.03784446 |
| 4 | MP0003724_increased_susceptibility_to | 2.91267921 |
| 5 | MP0003436_decreased_susceptibility_to | 2.89475231 |
| 6 | MP0000685_abnormal_immune_system | 2.89341597 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.80355825 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.69911026 |
| 9 | MP0005025_abnormal_response_to | 2.68527035 |
| 10 | MP0002419_abnormal_innate_immunity | 2.64549954 |
| 11 | MP0001800_abnormal_humoral_immune | 2.58433816 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.52660222 |
| 13 | MP0001790_abnormal_immune_system | 2.50973325 |
| 14 | MP0005387_immune_system_phenotype | 2.50973325 |
| 15 | MP0002396_abnormal_hematopoietic_system | 2.45314298 |
| 16 | MP0002723_abnormal_immune_serum | 2.38283656 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.37296616 |
| 18 | MP0001819_abnormal_immune_cell | 2.36105869 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.30109356 |
| 20 | MP0001853_heart_inflammation | 2.29459029 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.19302095 |
| 22 | MP0010155_abnormal_intestine_physiology | 2.10489643 |
| 23 | MP0002398_abnormal_bone_marrow | 2.08380042 |
| 24 | MP0006082_CNS_inflammation | 2.07864302 |
| 25 | MP0002166_altered_tumor_susceptibility | 1.99639572 |
| 26 | MP0002405_respiratory_system_inflammati | 1.99155457 |
| 27 | MP0006054_spinal_hemorrhage | 1.95152165 |
| 28 | MP0000716_abnormal_immune_system | 1.92388930 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.90324582 |
| 30 | MP0001873_stomach_inflammation | 1.88491292 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.87984690 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 1.85908528 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.85908528 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.80084277 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.78521158 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.77634735 |
| 37 | MP0002006_tumorigenesis | 1.75260348 |
| 38 | MP0000343_altered_response_to | 1.72169868 |
| 39 | MP0003300_gastrointestinal_ulcer | 1.69927340 |
| 40 | MP0004808_abnormal_hematopoietic_stem | 1.69133232 |
| 41 | MP0002722_abnormal_immune_system | 1.68388051 |
| 42 | MP0002429_abnormal_blood_cell | 1.68096151 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.65309998 |
| 44 | MP0003303_peritoneal_inflammation | 1.64278326 |
| 45 | MP0004947_skin_inflammation | 1.60903370 |
| 46 | MP0000490_abnormal_crypts_of | 1.57916692 |
| 47 | MP0008469_abnormal_protein_level | 1.46868584 |
| 48 | MP0009278_abnormal_bone_marrow | 1.45941754 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.43082206 |
| 50 | MP0003186_abnormal_redox_activity | 1.40962936 |
| 51 | MP0009764_decreased_sensitivity_to | 1.38611749 |
| 52 | MP0005310_abnormal_salivary_gland | 1.36804190 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 1.36651466 |
| 54 | MP0002933_joint_inflammation | 1.33788036 |
| 55 | MP0003866_abnormal_defecation | 1.30810340 |
| 56 | MP0000858_altered_metastatic_potential | 1.29701006 |
| 57 | MP0002138_abnormal_hepatobiliary_system | 1.28645476 |
| 58 | MP0004147_increased_porphyrin_level | 1.22742607 |
| 59 | MP0004381_abnormal_hair_follicle | 1.20464334 |
| 60 | MP0000703_abnormal_thymus_morphology | 1.19341554 |
| 61 | MP0008260_abnormal_autophagy | 1.14383933 |
| 62 | MP0002132_abnormal_respiratory_system | 1.13692422 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.13269840 |
| 64 | MP0003806_abnormal_nucleotide_metabolis | 1.13027405 |
| 65 | MP0004510_myositis | 1.12522233 |
| 66 | MP0005174_abnormal_tail_pigmentation | 1.06908414 |
| 67 | MP0003075_altered_response_to | 1.04296287 |
| 68 | MP0002277_abnormal_respiratory_mucosa | 1.03636840 |
| 69 | MP0003448_altered_tumor_morphology | 1.01332222 |
| 70 | MP0005075_abnormal_melanosome_morpholog | 1.00910786 |
| 71 | MP0004782_abnormal_surfactant_physiolog | 1.00297025 |
| 72 | MP0003172_abnormal_lysosome_physiology | 0.98334016 |
| 73 | MP0003828_pulmonary_edema | 0.96752044 |
| 74 | MP0001851_eye_inflammation | 0.92710032 |
| 75 | MP0008004_abnormal_stomach_pH | 0.91133945 |
| 76 | MP0002019_abnormal_tumor_incidence | 0.90826033 |
| 77 | MP0005166_decreased_susceptibility_to | 0.89992787 |
| 78 | MP0009840_abnormal_foam_cell | 0.88654068 |
| 79 | MP0000604_amyloidosis | 0.88154901 |
| 80 | MP0002998_abnormal_bone_remodeling | 0.86890539 |
| 81 | MP0001663_abnormal_digestive_system | 0.85935881 |
| 82 | MP0005167_abnormal_blood-brain_barrier | 0.82751930 |
| 83 | MP0009763_increased_sensitivity_to | 0.81965764 |
| 84 | MP0000249_abnormal_blood_vessel | 0.81891897 |
| 85 | MP0003045_fibrosis | 0.81666890 |
| 86 | MP0003279_aneurysm | 0.78665924 |
| 87 | MP0003943_abnormal_hepatobiliary_system | 0.77298734 |
| 88 | MP0001879_abnormal_lymphatic_vessel | 0.77176850 |
| 89 | MP0003690_abnormal_glial_cell | 0.76336910 |
| 90 | MP0009643_abnormal_urine_homeostasis | 0.75494822 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.74966665 |
| 92 | MP0005390_skeleton_phenotype | 0.74478897 |
| 93 | MP0008875_abnormal_xenobiotic_pharmacok | 0.74013782 |
| 94 | MP0002009_preneoplasia | 0.74007758 |
| 95 | MP0001765_abnormal_ion_homeostasis | 0.73165208 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 0.71090821 |
| 97 | MP0003252_abnormal_bile_duct | 0.69499731 |
| 98 | MP0005451_abnormal_body_composition | 0.67890351 |
| 99 | MP0008007_abnormal_cellular_replicative | 0.67065751 |
| 100 | MP0002095_abnormal_skin_pigmentation | 0.65040585 |
| 101 | MP0005164_abnormal_response_to | 0.64580949 |
| 102 | MP0005023_abnormal_wound_healing | 0.64457815 |
| 103 | MP0003795_abnormal_bone_structure | 0.64424264 |
| 104 | MP0005365_abnormal_bile_salt | 0.62251502 |
| 105 | MP0000015_abnormal_ear_pigmentation | 0.62165532 |
| 106 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62094926 |
| 107 | MP0005085_abnormal_gallbladder_physiolo | 0.62038705 |
| 108 | MP0005165_increased_susceptibility_to | 0.61125557 |
| 109 | MP0003453_abnormal_keratinocyte_physiol | 0.59688058 |
| 110 | MP0008874_decreased_physiological_sensi | 0.59045465 |
| 111 | MP0003638_abnormal_response/metabolism_ | 0.58483887 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.56776291 |
| 113 | MP0000477_abnormal_intestine_morphology | 0.56660070 |
| 114 | MP0001191_abnormal_skin_condition | 0.54310237 |
| 115 | MP0000598_abnormal_liver_morphology | 0.53763701 |
| 116 | MP0004883_abnormal_blood_vessel | 0.52977629 |
| 117 | MP0008873_increased_physiological_sensi | 0.52051020 |
| 118 | MP0000609_abnormal_liver_physiology | 0.50694581 |
| 119 | MP0009765_abnormal_xenobiotic_induced | 0.50641231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.37344100 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.82422314 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.67895786 |
| 4 | Myositis (HP:0100614) | 4.58272697 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.29828520 |
| 6 | IgM deficiency (HP:0002850) | 4.18326399 |
| 7 | Chronic otitis media (HP:0000389) | 4.00947023 |
| 8 | Orchitis (HP:0100796) | 3.74798572 |
| 9 | Abnormality of macrophages (HP:0004311) | 3.72880749 |
| 10 | Petechiae (HP:0000967) | 3.70651979 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 3.68981144 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.64058767 |
| 13 | Thrombocytosis (HP:0001894) | 3.57387645 |
| 14 | Pustule (HP:0200039) | 3.53446284 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 3.51474956 |
| 16 | Optic neuritis (HP:0100653) | 3.44822978 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.44822978 |
| 18 | Recurrent bronchitis (HP:0002837) | 3.44491956 |
| 19 | Recurrent viral infections (HP:0004429) | 3.40681618 |
| 20 | Increased IgM level (HP:0003496) | 3.32603168 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.30900618 |
| 22 | Recurrent skin infections (HP:0001581) | 3.28448879 |
| 23 | Cellulitis (HP:0100658) | 3.26092649 |
| 24 | Agammaglobulinemia (HP:0004432) | 3.20553895 |
| 25 | Autoimmune thrombocytopenia (HP:0001973) | 3.20266706 |
| 26 | Meningitis (HP:0001287) | 3.15078568 |
| 27 | Interstitial pulmonary disease (HP:0006530) | 3.14817153 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 3.11216110 |
| 29 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.08853606 |
| 30 | Vasculitis (HP:0002633) | 3.02657359 |
| 31 | Spontaneous hematomas (HP:0007420) | 3.01533684 |
| 32 | Abnormality of T cell physiology (HP:0011840) | 3.00328183 |
| 33 | Increased cerebral lipofuscin (HP:0011813) | 2.93118058 |
| 34 | Gastrointestinal stroma tumor (HP:0100723) | 2.86646979 |
| 35 | Abnormality of T cells (HP:0002843) | 2.85312024 |
| 36 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.80078180 |
| 37 | Periodontitis (HP:0000704) | 2.78339669 |
| 38 | Inflammation of the large intestine (HP:0002037) | 2.76733949 |
| 39 | Panhypogammaglobulinemia (HP:0003139) | 2.74501469 |
| 40 | Increased IgE level (HP:0003212) | 2.73392723 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.70781844 |
| 42 | Recurrent cutaneous fungal infections (HP:0011370) | 2.70781844 |
| 43 | Abnormality of the nasal mucosa (HP:0000433) | 2.70733550 |
| 44 | Abnormality of glycolipid metabolism (HP:0010969) | 2.70289229 |
| 45 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.70289229 |
| 46 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.70289229 |
| 47 | Obstructive lung disease (HP:0006536) | 2.69733606 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 2.69733606 |
| 49 | Aplastic anemia (HP:0001915) | 2.69080820 |
| 50 | Prolonged bleeding time (HP:0003010) | 2.67977494 |
| 51 | IgG deficiency (HP:0004315) | 2.65846058 |
| 52 | Gastrointestinal inflammation (HP:0004386) | 2.64861153 |
| 53 | Lymphopenia (HP:0001888) | 2.58435211 |
| 54 | Osteomyelitis (HP:0002754) | 2.57045394 |
| 55 | Keratoconjunctivitis sicca (HP:0001097) | 2.55539411 |
| 56 | Gangrene (HP:0100758) | 2.54315547 |
| 57 | Colitis (HP:0002583) | 2.53476716 |
| 58 | Pulmonary embolism (HP:0002204) | 2.52799233 |
| 59 | Abnormality of T cell number (HP:0011839) | 2.52216953 |
| 60 | Arterial thrombosis (HP:0004420) | 2.51943016 |
| 61 | Stomatitis (HP:0010280) | 2.51623429 |
| 62 | Pulmonary infiltrates (HP:0002113) | 2.50637143 |
| 63 | Epistaxis (HP:0000421) | 2.49869339 |
| 64 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.49279355 |
| 65 | Nasal polyposis (HP:0100582) | 2.49007920 |
| 66 | T lymphocytopenia (HP:0005403) | 2.40565494 |
| 67 | Anorexia (HP:0002039) | 2.40039495 |
| 68 | Urticaria (HP:0001025) | 2.39105317 |
| 69 | Leukocytosis (HP:0001974) | 2.38388178 |
| 70 | Purpura (HP:0000979) | 2.37721643 |
| 71 | Joint swelling (HP:0001386) | 2.35419474 |
| 72 | Encephalitis (HP:0002383) | 2.34663901 |
| 73 | Abnormality of the prostate (HP:0008775) | 2.32211776 |
| 74 | Keratoconjunctivitis (HP:0001096) | 2.32030795 |
| 75 | Abnormality of the pleura (HP:0002103) | 2.31623866 |
| 76 | Episodic fever (HP:0001954) | 2.30762461 |
| 77 | Chronic diarrhea (HP:0002028) | 2.28343057 |
| 78 | Systemic lupus erythematosus (HP:0002725) | 2.27721201 |
| 79 | Gingivitis (HP:0000230) | 2.25485167 |
| 80 | Hemoptysis (HP:0002105) | 2.25113862 |
| 81 | Dysostosis multiplex (HP:0000943) | 2.23971156 |
| 82 | IgA deficiency (HP:0002720) | 2.22409321 |
| 83 | Gingival bleeding (HP:0000225) | 2.19788626 |
| 84 | Abnormality of B cell number (HP:0010975) | 2.18305390 |
| 85 | B lymphocytopenia (HP:0010976) | 2.18305390 |
| 86 | Neutropenia (HP:0001875) | 2.16814282 |
| 87 | Poor head control (HP:0002421) | 2.16386873 |
| 88 | Amyloidosis (HP:0011034) | 2.13918785 |
| 89 | Recurrent pneumonia (HP:0006532) | 2.13818970 |
| 90 | Increased serum ferritin (HP:0003281) | 2.12757952 |
| 91 | Abnormality of iron homeostasis (HP:0011031) | 2.12279763 |
| 92 | Recurrent sinusitis (HP:0011108) | 2.12147835 |
| 93 | Impaired platelet aggregation (HP:0003540) | 2.11596517 |
| 94 | Abnormal platelet function (HP:0011869) | 2.11596517 |
| 95 | Skin ulcer (HP:0200042) | 2.11043672 |
| 96 | Hepatosplenomegaly (HP:0001433) | 2.10666301 |
| 97 | Basal ganglia calcification (HP:0002135) | 2.09194617 |
| 98 | Eosinophilia (HP:0001880) | 2.08556546 |
| 99 | Abnormality of eosinophils (HP:0001879) | 2.07309565 |
| 100 | Recurrent lower respiratory tract infections (HP:0002783) | 2.05974835 |
| 101 | Vertigo (HP:0002321) | 2.05153661 |
| 102 | Hypergammaglobulinemia (HP:0010702) | 2.04500321 |
| 103 | Skin rash (HP:0000988) | 2.04215067 |
| 104 | Hematochezia (HP:0002573) | 2.04038315 |
| 105 | Loss of speech (HP:0002371) | 2.03619779 |
| 106 | Glomerulopathy (HP:0100820) | 2.02670575 |
| 107 | Reduced antithrombin III activity (HP:0001976) | 2.01823424 |
| 108 | Polyneuropathy (HP:0001271) | 2.01476372 |
| 109 | Granulocytopenia (HP:0001913) | 2.01368751 |
| 110 | Acute hepatic failure (HP:0006554) | 2.01289248 |
| 111 | Bronchitis (HP:0012387) | 2.00209236 |
| 112 | Chest pain (HP:0100749) | 1.99608474 |
| 113 | Hypochromic anemia (HP:0001931) | 1.99203015 |
| 114 | Thyroiditis (HP:0100646) | 1.99075726 |
| 115 | Sepsis (HP:0100806) | 1.98122224 |
| 116 | Combined immunodeficiency (HP:0005387) | 1.97689995 |
| 117 | Lymphoma (HP:0002665) | 1.97470581 |
| 118 | Pulmonary fibrosis (HP:0002206) | 1.96743409 |
| 119 | Severe combined immunodeficiency (HP:0004430) | 1.96259458 |
| 120 | Fatigue (HP:0012378) | 1.96166922 |
| 121 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.94302159 |
| 122 | Arthralgia (HP:0002829) | 1.93960070 |
| 123 | Hypoproteinemia (HP:0003075) | 1.93862516 |
| 124 | Verrucae (HP:0200043) | 1.89929735 |
| 125 | Papilloma (HP:0012740) | 1.89929735 |
| 126 | Autoimmune hemolytic anemia (HP:0001890) | 1.89258755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.02783739 |
| 2 | TXK | 2.98656592 |
| 3 | KIT | 2.90482991 |
| 4 | MAP3K14 | 2.66753115 |
| 5 | TBK1 | 2.55887515 |
| 6 | JAK3 | 2.45820002 |
| 7 | BTK | 2.40533420 |
| 8 | IRAK4 | 2.39752237 |
| 9 | BLK | 2.34441549 |
| 10 | ZAP70 | 2.27366265 |
| 11 | TEC | 2.20275613 |
| 12 | IKBKE | 2.08870719 |
| 13 | TYK2 | 2.08044276 |
| 14 | STK10 | 2.01820398 |
| 15 | KDR | 1.99755561 |
| 16 | ERN1 | 1.98855107 |
| 17 | TGFBR2 | 1.86880294 |
| 18 | MST4 | 1.85335876 |
| 19 | PIM2 | 1.81353259 |
| 20 | TNK2 | 1.68072499 |
| 21 | LRRK2 | 1.64367561 |
| 22 | IRAK3 | 1.60911567 |
| 23 | CSF1R | 1.60448442 |
| 24 | IKBKB | 1.59395141 |
| 25 | NEK9 | 1.57727497 |
| 26 | SYK | 1.52106615 |
| 27 | MAP2K3 | 1.50100719 |
| 28 | ITK | 1.48043853 |
| 29 | MAP3K12 | 1.45799449 |
| 30 | EPHB1 | 1.38846615 |
| 31 | FLT3 | 1.38492302 |
| 32 | TAOK3 | 1.37733859 |
| 33 | TIE1 | 1.26735942 |
| 34 | MATK | 1.25956897 |
| 35 | PRPF4B | 1.25388568 |
| 36 | RPS6KA4 | 1.24153680 |
| 37 | LYN | 1.22896453 |
| 38 | MYLK | 1.18172443 |
| 39 | TGFBR1 | 1.17092572 |
| 40 | LCK | 1.12551462 |
| 41 | JAK1 | 1.11656792 |
| 42 | CSK | 1.10220365 |
| 43 | CHUK | 1.09318055 |
| 44 | PIM1 | 1.07947453 |
| 45 | ACVR1B | 1.00765131 |
| 46 | MAPKAPK3 | 0.97929085 |
| 47 | BRSK2 | 0.97270123 |
| 48 | TRIB3 | 0.95818759 |
| 49 | FGR | 0.95364352 |
| 50 | STK24 | 0.95270039 |
| 51 | HCK | 0.94626518 |
| 52 | PIK3CG | 0.93542835 |
| 53 | PIK3CA | 0.93500617 |
| 54 | GRK7 | 0.92439550 |
| 55 | NME2 | 0.90888334 |
| 56 | CAMKK2 | 0.90793250 |
| 57 | CLK1 | 0.90138120 |
| 58 | MAP2K2 | 0.89779645 |
| 59 | NLK | 0.89399421 |
| 60 | GRK6 | 0.85058496 |
| 61 | MAP3K1 | 0.82738273 |
| 62 | TAOK1 | 0.80255885 |
| 63 | PDK1 | 0.80138216 |
| 64 | TRPM7 | 0.79462593 |
| 65 | FGFR4 | 0.79294376 |
| 66 | RIPK4 | 0.78044937 |
| 67 | SIK3 | 0.76960900 |
| 68 | JAK2 | 0.74873211 |
| 69 | MAPKAPK5 | 0.73222987 |
| 70 | PAK4 | 0.71750716 |
| 71 | STK4 | 0.70899465 |
| 72 | TAOK2 | 0.70690508 |
| 73 | CAMKK1 | 0.66636729 |
| 74 | FYN | 0.66112824 |
| 75 | EIF2AK3 | 0.64267383 |
| 76 | NUAK1 | 0.63053356 |
| 77 | TESK2 | 0.62742268 |
| 78 | MAPKAPK2 | 0.61106522 |
| 79 | MAP3K13 | 0.61058632 |
| 80 | EEF2K | 0.59111008 |
| 81 | FGFR3 | 0.58353331 |
| 82 | PTK2B | 0.57882863 |
| 83 | EIF2AK1 | 0.57755079 |
| 84 | MAPK7 | 0.57685983 |
| 85 | MAP2K6 | 0.55916881 |
| 86 | PRKCQ | 0.55587562 |
| 87 | ILK | 0.55540812 |
| 88 | CCNB1 | 0.55536267 |
| 89 | HIPK2 | 0.55026336 |
| 90 | BCKDK | 0.54060650 |
| 91 | MARK3 | 0.53846507 |
| 92 | PRKCD | 0.53688121 |
| 93 | CDK8 | 0.53514386 |
| 94 | MAP3K3 | 0.53198475 |
| 95 | VRK1 | 0.53089937 |
| 96 | FES | 0.52467703 |
| 97 | MAPK12 | 0.51380610 |
| 98 | MAP3K5 | 0.51325001 |
| 99 | PKN2 | 0.51243644 |
| 100 | TESK1 | 0.50471255 |
| 101 | PRKG2 | 0.50373537 |
| 102 | RIPK1 | 0.49810192 |
| 103 | ADRBK2 | 0.49795948 |
| 104 | PTK6 | 0.49442904 |
| 105 | PDPK1 | 0.48616650 |
| 106 | MAP3K11 | 0.44997014 |
| 107 | YES1 | 0.44225211 |
| 108 | STK3 | 0.42912140 |
| 109 | RPS6KA6 | 0.42521419 |
| 110 | SCYL2 | 0.41497014 |
| 111 | IRAK1 | 0.40805922 |
| 112 | MAP3K10 | 0.40577863 |
| 113 | IRAK2 | 0.39744456 |
| 114 | CDK6 | 0.38463842 |
| 115 | MAPK4 | 0.38338415 |
| 116 | BMPR2 | 0.37566602 |
| 117 | TLK1 | 0.37439130 |
| 118 | EPHA3 | 0.37366166 |
| 119 | DMPK | 0.35877766 |
| 120 | STK16 | 0.34117215 |
| 121 | DAPK1 | 0.33684864 |
| 122 | ABL1 | 0.32975573 |
| 123 | IGF1R | 0.32548715 |
| 124 | RPS6KB2 | 0.32332907 |
| 125 | PRKD2 | 0.31678470 |
| 126 | GRK5 | 0.31094252 |
| 127 | PBK | 0.30563968 |
| 128 | MAP4K2 | 0.29253567 |
| 129 | MAPK11 | 0.29190085 |
| 130 | DAPK2 | 0.28297169 |
| 131 | SIK2 | 0.26753888 |
| 132 | NEK6 | 0.26751793 |
| 133 | MAPK3 | 0.26485595 |
| 134 | MAP3K7 | 0.26427667 |
| 135 | PRKD1 | 0.22983717 |
| 136 | KSR2 | 0.22020728 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.93809540 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.92819258 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.50873363 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.47532023 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.40838598 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.37862218 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.21908467 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.19868273 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.07268949 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.06538401 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.02513425 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.02214566 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.99264561 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.97836246 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.96862796 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.95664722 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.80752359 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.80051071 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.77468977 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.71286777 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.69441061 |
| 22 | Shigellosis_Homo sapiens_hsa05131 | 1.67306421 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.64492322 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.62818049 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.59175969 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.55157703 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.47841711 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.47787567 |
| 29 | DNA replication_Homo sapiens_hsa03030 | 1.47544371 |
| 30 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.43486680 |
| 31 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.41102571 |
| 32 | Lysosome_Homo sapiens_hsa04142 | 1.37385307 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.36007127 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.33701774 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.29762954 |
| 36 | Base excision repair_Homo sapiens_hsa03410 | 1.29051275 |
| 37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.27681190 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25677989 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.25297025 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.25211661 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.24097037 |
| 42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.16836272 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.16212821 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.14041872 |
| 45 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.09702073 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08958679 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07615474 |
| 48 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.07125791 |
| 49 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03137774 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.00362257 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.99621243 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95043097 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.94848679 |
| 54 | Protein export_Homo sapiens_hsa03060 | 0.94637258 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.94435476 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91837111 |
| 57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89271516 |
| 58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88969107 |
| 59 | Proteasome_Homo sapiens_hsa03050 | 0.87768787 |
| 60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.87035091 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85142520 |
| 62 | Mismatch repair_Homo sapiens_hsa03430 | 0.84961777 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 0.83616962 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.80231281 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79445662 |
| 66 | Ribosome_Homo sapiens_hsa03010 | 0.76976857 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76913367 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71943184 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71562821 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.66473570 |
| 71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.65861848 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64564436 |
| 73 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.63542922 |
| 74 | Homologous recombination_Homo sapiens_hsa03440 | 0.61515065 |
| 75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59835621 |
| 76 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59649127 |
| 77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59536607 |
| 78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54266092 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53748396 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53399404 |
| 81 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51920850 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50787400 |
| 83 | Cell cycle_Homo sapiens_hsa04110 | 0.48840469 |
| 84 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.44424449 |
| 85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44177157 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43774141 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41077469 |
| 88 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.40614848 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.38824333 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37912167 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37013594 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35247289 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34274082 |
| 94 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.33435484 |
| 95 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33280039 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32929583 |
| 97 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.32634793 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32062176 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.31585818 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.30707714 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30178152 |
| 102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30082436 |
| 103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26770481 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.25738220 |
| 105 | RNA polymerase_Homo sapiens_hsa03020 | 0.25689921 |
| 106 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.25489072 |
| 107 | RNA degradation_Homo sapiens_hsa03018 | 0.25386799 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25140811 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25082039 |
| 110 | Histidine metabolism_Homo sapiens_hsa00340 | 0.24742136 |
| 111 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.23809966 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | 0.23537978 |
| 113 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22706017 |
| 114 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.21903718 |
| 115 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21199905 |
| 116 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.20572947 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.19649299 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.17637340 |
| 119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.16759419 |
| 120 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.16043337 |
| 121 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.14776945 |
| 122 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.14533327 |
| 123 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.12637192 |
| 124 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.11922290 |
| 125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.11518471 |
| 126 | ABC transporters_Homo sapiens_hsa02010 | 0.11102098 |
| 127 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.09877273 |
| 128 | Renin secretion_Homo sapiens_hsa04924 | 0.09798873 |

